

Publisher: Karger
E-ISSN: 1423-0100|43|4-6|322-330
ISSN: 0300-5526
Source: Intervirology, Vol.43, Iss.4-6, 2001-02, pp. : 322-330
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Influenza A virus with its two major antigenic surface proteins hemagglutinin (HA) and neuraminidase (NA) is a widely used model to study DNA immunizations in mice and other animals. Natural protection against influenza A virus infection is mediated by antibodies, which mostly are not protective against antigenic shift or drift variants of the original virus. Therefore, it would be a major task to induce a protective cellular immune re- sponse to more conserved proteins or epitopes. Injection of plasmid encoding a viral antigen is known to induce cellular as well as humoral immunity. In this study we investigate the mechanism of protection after intramuscular vaccination of C57Bl/6 mice with a DNA vaccine encoding HA of influenza A/PR/8/34. After a single injection, only a small percentage of mice survive the lethal challenge with homologous virus. The amount of protection can be doubled by applying a booster injection. Furthermore, by coinjection of plasmids encoding cytokines GM-CSF and IL-12, respectively, nearly all of the mice are protected. Mice with specific defects in the cellular immune response [perforin knockout (P–/–) mice] and in the humoral immune response [IgD/IgM knockout (µMT) mice], respectively, have been immunized with HA DNA with or without cytokine DNA. Protection could only be induced in P–/– mice, whereas µMT mice succumbed to the infection. Moreover, when µMT mice were infected with only 0.75 ×50% lethal dose they died all the same, whereby mice that had been depleted of CD8+ T cells before infection showed an even greater progression of illness. Altogether these results demonstrate that antibodies mediate protection after immunization with plasmid coding for HA of influenza A virus, and that booster immunizations and coinjection of plasmids encoding GM-CSF or IL-12 can improve this protection.
Related content






By Zhang Wenlong Yin Zhe Liu Nihong Yang Tao Wang Junwei Bu Zhigao Wu Donglai
Journal of Microencapsulation, Vol. 27, Iss. 8, 2010-12 ,pp. :


Anaphylaxis from the Influenza Virus Vaccine
International Archives of Allergy and Immunology, Vol. 146, Iss. 1, 2007-12 ,pp. :


Intervirology, Vol. 50, Iss. 1, 2006-11 ,pp. :